Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year

IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

See all formats and pricing


Select Volume and Issue


Hematopoietic cytokines as tumor markers

Barbara Mroczko
  • Department of Biochemical Diagnostics, Medical Academy, Bialystok, Poland
/ Maciej Szmitkowski
  • Department of Biochemical Diagnostics, Medical Academy, Bialystok, Poland
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.2004.253


Stem cell factor (SCF), interleukin 3 (IL-3), granulocyte-macrophage-colony stimulating factor (GM-CSF), granulocyte-colony stimulating factor (G-CSF) and macrophage-colony stimulating factor (M-CSF) are members of a group of glycoproteins called hematopoietic cytokines (HCs). These cytokines regulate the growth and differentiation of hematopoietic progenitor cells and functionally activate mature neutrophils or macrophages. The effect of HCs is not limited to bone marrow cells. Some studies have shown that HCs can also stimulate the proliferation of non-hematopoietic cells. The receptors for HCs have been detected in cancer cell lines, and stimulation of HCs receptors induced proliferation of tumor cells. Moreover, some investigations have shown HC mRNA expression in these cell lines and recent studies have demonstrated that HCs can stimulate tumor progression. Several cells of malignant tumors have been observed to secrete large amounts of HCs and increased concentrations of HCs have been found in the sera of cancer patients. There are a number of situations in which the measurement of HCs may provide clinically useful information, particularly regarding prognosis and response to treatment. In this paper we discuss the results of studies that have examined the potential use of HCs as tumor markers.

Keywords: hematopoietic cytokines; tumor markers

Corresponding author: M. Szmitkowski, MD, PhD, Department of Biochemical Diagnostics, Medical Academy, M. Sklodowska-Curie 24A, 15-276 Bialystok, Poland Phone: +48-85-7468587, Fax: +48-85-7468585,

Received: December 16, 2003

Accepted: September 7, 2004

Published Online: 2005-06-01

Published in Print: 2004-12-01

Citation Information: Clinical Chemical Laboratory Medicine. Volume 42, Issue 12, Pages 1347–1354, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2004.253, June 2005

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Claudia M. Gutschalk, Archana K. Yanamandra, Nina Linde, Alice Meides, Sofia Depner, and Margareta M. Mueller
Cancer Medicine, 2013, Volume 2, Number 2, Page 117
Daniel Buergy, Frederik Wenz, Christoph Groden, and Marc A. Brockmann
International Journal of Cancer, 2012, Volume 130, Number 12, Page 2747
Yuanyuan Ma, Dongming Liang, Jian Liu, Karol Axcrona, Gunnar Kvalheim, Karl-Erik Giercksky, Jahn M. Nesland, and Zhenhe Suo
Tumor Biology, 2012, Volume 33, Number 4, Page 967
Luciano S. Hammes, Rajeshwar Rao Tekmal, Paulo Naud, Maria Isabel Edelweiss, Nameer Kirma, Philip T. Valente, Kari J. Syrjänen, and João Sabino Cunha-Filho
Gynecologic Oncology, 2008, Volume 110, Number 3, Page 445
Barbara Mroczko, Magdalena Groblewska, Urszula Wereszczynska-Siemiatkowska, Bogusław Kedra, Marzena Konopko, and Maciej Szmitkowski
Clinica Chimica Acta, 2006, Volume 371, Number 1-2, Page 143
John R. Wingard and Mohamed Elmongy
Critical Reviews in Oncology/Hematology, 2009, Volume 72, Number 2, Page 144
Eva Freisinger, Christopher Cramer, Xiujin Xia, Subramanyam N. Murthy, Douglas P. Slakey, Ernest Chiu, Edward R. Newsome, Eckhard U. Alt, and Reza Izadpanah
Journal of Cellular Physiology, 2010, Volume 225, Number 3, Page 888
Kazuaki Chikamatsu, Goro Takahashi, Koichi Sakakura, Soldano Ferrone, and Keisuke Masuyama
Head & Neck, 2011, Volume 33, Number 2, Page 208
Karsten Münstedt, Andreas Hackethal, Kosai Eskef, Igor Hrgovic, and Folker E. Franke
Archives of Gynecology and Obstetrics, 2010, Volume 282, Number 3, Page 301
L. M. Skivka, G. V. Gorbik, O. G. Fedorchuk, and V. V. Pozur
Cytology and Genetics, 2009, Volume 43, Number 4, Page 283
Jung Sub Song, So Young Kim, Hyang Jeong Jo, Kang Kyoo Lee, Jeong Hyun Shin, Seong Nam Shin, Dong Kim, Seong Hoon Park, Young Jin Lee, Chang Bo Ko, Mi Kung Lee, Soon Ho Choi, Jong Hoon Jeong, Jung Hyun Park, Hui Jung Kim, Hak Ryul Kim, Eun Taik Jeong, and Sei Hoon Yang
Tuberculosis and Respiratory Diseases, 2009, Volume 66, Number 6, Page 444

Comments (0)

Please log in or register to comment.